bpc 157 fda warning 2025 october bpc-157 news FDA intends to exempt certain unclassified medical devices from premarket notification BPC-157 Before the FDA: Briefing
Description
Causes of deficiency can include an insufficient diet of animal products, gastrointestinal problems that affect absorption, and certain autoimmune medical conditions
The scientific community has increasingly recognized numerous advantages of peptides over small molecules and biological agents
Quality sourcing and appropriate protocols minimize but do not eliminate potential risks
Alternatively, oral capsules are available but have significantly lower bioavailability
